[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Moderna Inc (MRNA)

Moderna Inc (MRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
FDA panel backs first-of-its-kind flu vaccine using mRNA technology

A new kind of flu vaccine is moving a step closer to the U.S. market

MRNA : 63.96 (+3.50%)
Moderna Announces FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010, an Investigational Seasonal Influenza Vaccine

FDA Prescription Drug User Fee Act (PDUFA) goal date remains August 5, 2026

MRNA : 63.96 (+3.50%)
Moderna to Host Investor Event - Science Day

CAMBRIDGE, MA / ACCESS Newswire / June 17, 2026 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event - Science Day at 9:00am ET on Thursday, June 25, 2026.

MRNA : 63.96 (+3.50%)
Nasdaq Futures Climb as Chip Stocks Rebound Ahead of First Fed Decision Under Warsh

June Nasdaq 100 E-Mini futures (NQM26) are up +0.54% this morning, signaling a rebound from yesterday’s selloff, while investors await the first Federal Reserve rate decision under Kevin Warsh.

KLAC : 259.56 (+8.73%)
MU : 1,133.99 (+8.70%)
RMD : 188.63 (+1.26%)
CBOE : 249.10 (-2.19%)
BMW.D.DX : 60.060 (+0.64%)
STMN.Z.IX : 104.950 (-0.14%)
SPCX : 185.00 (-3.56%)
LZB : 39.66 (-1.44%)
INTC : 133.99 (+10.64%)
NOW : 95.04 (-0.46%)
TEAM : 82.72 (-1.98%)
MRNA : 63.96 (+3.50%)
Why Is Moderna (MRNA) Stock Soaring Today

Why Is Moderna (MRNA) Stock Soaring Today

MRNA : 63.96 (+3.50%)
Moderna Announces Organizational Changes to Prepare for Multiple Product Launches in 2027 and 2028

Dr. Stephen Hoge, President of Moderna, to Assume an Expanded Role With Operational Oversight of the Company's Infectious Disease, Intismeran and Rare Disease Franchises

MRNA : 63.96 (+3.50%)
3 Stocks Under $50 That Fall Short

3 Stocks Under $50 That Fall Short

RELL : 18.60 (+6.59%)
WBD : 26.20 (-0.15%)
MRNA : 63.96 (+3.50%)
How to Play PBLS Stock After the Parabilis IPO

Parabilis stock soared on its Nasdaq debut, but a deeper dive suggests PBLS shares could extend gains further through the remainder of 2026.

KLRA : 19.90 (+4.03%)
PBLS : 25.85 (-0.69%)
MRNA : 63.96 (+3.50%)
3 Unpopular Stocks We Steer Clear Of

3 Unpopular Stocks We Steer Clear Of

NOV : 18.66 (-3.32%)
RPD : 6.73 (-0.59%)
MRNA : 63.96 (+3.50%)
Moderna and the University of Oxford Receive UK Authorization to Begin Phase 1/2 Study of Investigational mRNA Cancer Vaccine for People with Lynch Syndrome

Lynch syndrome is an inherited condition affecting 1 in 300 people that causes lifetime cancer risk of up to 80%[1]

MRNA : 63.96 (+3.50%)

Barchart Exclusives

Cathie Wood Loads Up on SpaceX Stock. She Is Betting Big That Musk’s AI Vision Will Pay Off.
Cathie Wood’s aggressive buying signals strong confidence in SpaceX, but investors must decide whether Elon Musk’s ambitious AI vision can ultimately justify the company’s lofty valuation. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.